Cargando…
Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression
We investigated whether aspartate transaminase (AST)-to-alanine aminotransferase (ALT) ratio and its change during the course of treatment in castration-resistant prostate cancer (CRPC) patients is associated with tumor condition and lethality. Clinical data from 130 CRPC patients were retrospective...
Autores principales: | Mitsui, Yozo, Yamabe, Fumito, Hori, Shunsuke, Uetani, Masato, Aoki, Hiroshi, Sakurabayashi, Kei, Okawa, Mizuho, Kobayashi, Hideyuki, Nagao, Koichi, Nakajima, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504303/ https://www.ncbi.nlm.nih.gov/pubmed/37714917 http://dx.doi.org/10.1038/s41598-023-42711-z |
Ejemplares similares
-
Combination of C-reactive protein/albumin ratio and time to castration resistance enhances prediction of prognosis for patients with metastatic castration-resistant prostate cancer
por: Mitsui, Yozo, et al.
Publicado: (2023) -
Successful treatment of ejaculation pain with silodosin in patient with Zinner syndrome: a case report
por: Uetani, Masato, et al.
Publicado: (2023) -
Urine pH and imaging findings of prostate useful predictors of prolonged duration of hematospermia
por: Mitsui, Yozo, et al.
Publicado: (2023) -
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie’s Disease
por: Mitsui, Yozo, et al.
Publicado: (2023) -
Colon Cancer Metastasis to the Right Testis: Case Report and Review of Literature
por: Kasahara, Mizuki, et al.
Publicado: (2022)